1 序文
2 調査範囲と方法論
2.1 調査の目的
2.2 ステークホルダー
2.3 データソース
2.3.1 一次情報源
2.3.2 二次情報源
2.4 市場推定
2.4.1 ボトムアップ・アプローチ
2.4.2 トップダウンアプローチ
2.5 予測方法
3 エグゼクティブ・サマリー
4 はじめに
4.1 概要
4.2 主要業界動向
5 世界の医薬品受託包装業界
5.1 市場概要
5.2 市場パフォーマンス
5.3 COVID-19の影響
5.4 価格分析
5.4.1 主要価格指標
5.4.2 価格構造
5.4.3 価格動向
5.5 産業別市場構成
5.6 タイプ別市場構成
5.7 包装別市場構成比
5.8 地域別市場構成比
5.9 市場予測
5.10 SWOT分析
5.10.1 概要
5.10.2 強み
5.10.3 弱点
5.10.4 機会
5.10.5 脅威
5.11 バリューチェーン分析
5.11.1 原材料調達
5.11.2 製造
5.11.3 マーケティング
5.11.4 流通
5.11.5 輸出
5.11.6 最終用途
5.12 ポーターのファイブフォース分析
5.12.1 概要
5.12.2 買い手の交渉力
5.12.3 供給者の交渉力
5.12.4 競争の程度
5.12.5 新規参入の脅威
5.12.6 代替品の脅威
5.13 ジェネリック業界における規制
5.14 主な市場促進要因と成功要因
6 産業別市場構成
6.1 低分子
6.1.1 市場動向
6.1.2 市場予測
6.2 バイオ医薬品
6.2.1 市場動向
6.2.2 市場予測
6.3 ワクチン
6.3.1 市場動向
6.3.2 市場予測
7 タイプ別市場
7.1 無菌
7.1.1 市場動向
7.1.2 市場予測
7.2 非ステライル
7.2.1 市場動向
7.2.2 市場予測
8 包装別市場内訳
8.1 プラスチックボトル
8.1.1 市場動向
8.1.2 市場予測
8.2 キャップ・クロージャー
8.2.1 市場動向
8.2.2 市場予測
8.3 ブリスターパック
8.3.1 市場動向
8.3.2 市場予測
8.4 プレフィルドシリンジ
8.4.1 市場動向
8.4.2 市場予測
8.5 非経口バイアル・アンプル
8.5.1 市場動向
8.5.2 市場予測
8.6 その他
8.6.1 市場動向
8.6.2 市場予測
9 地域別市場内訳
9.1 米国
9.1.1 市場動向
9.1.2 市場予測
9.2 欧州
9.2.1 市場動向
9.2.2 市場予測
9.3 中国
9.3.1 市場動向
9.3.2 市場予測
9.4 インド
9.4.1 市場動向
9.4.2 市場予測
9.5 その他
9.5.1 市場動向
9.5.2 市場予測
10 競争環境
10.1 市場構造
10.2 主要プレイヤー
11 医薬品受託包装プロセス
11.1 製品概要
11.2 詳細なプロセスフロー
11.3 様々な種類のユニットオペレーション
11.4 マスバランスと原材料要件
12 プロジェクトの詳細、要件、および関連費用
12.1 土地要件と費用
12.2 建設要件と費用
12.3 工場レイアウト
12.4 工場機械
12.5 原材料の要件と支出
12.6 輸送要件および支出
12.7 ユーティリティ要件および支出
12.8 人員要件および支出
12.9 その他の設備投資
13 ローンと資金援助
14 プロジェクトの経済性
14.1 プロジェクトの資本コスト
14.2 技術経済パラメータ
14.3 サプライチェーンの各段階における製品価格とマージン
14.4 課税と減価償却
14.5 収入予測
14.6 支出予測
14.7 財務分析
14.8 利益分析
15 主要プレーヤーのプロフィール
図1：世界：医薬品受託包装市場：主な推進要因と課題
図2：世界：医薬品受託包装市場：図2：医薬品受託包装の世界市場：販売額推移（単位：億米ドル）、2019年〜2024年
図3：医薬品受託包装の世界市場予測：販売額推移（単位：億米ドル）、2025年～2033年
図4：医薬品受託包装の世界市場：図4：医薬品受託包装の世界市場：産業別構成比（単位：%）、2024年
図5：医薬品受託包装の世界市場：タイプ別構成比（%）、2024年図5：医薬品受託包装の世界市場：タイプ別構成比（%）、2024年
図6：医薬品受託包装の世界市場：タイプ別構成比（%）、2024年図6：医薬品受託包装市場のタイプ別構成比（%）、2024年
図7：医薬品受託包装の世界市場：包装別構成比（%）、2024年図7：医薬品受託包装の世界市場：地域別構成比（%）、2024年
図8：世界：医薬品受託包装業界：SWOT分析
図9: 医薬品受託包装の世界市場：バリューチェーン分析バリューチェーン分析
図10: 医薬品受託包装業界の世界：バリューチェーン分析：ポーターのファイブフォース分析
図11: 米国：医薬品受託包装市場（単位：百万米ドル）、2019年 & 2024年
図12: 米国：医薬品受託包装市場の予測（単位：百万米ドル）、2025年～2033年
図13: 欧州：医薬品受託包装市場（単位：百万米ドル）、2019年および2024年
図14: 欧州：医薬品受託包装市場の予測（単位：百万米ドル）、2025年～2033年
図15: 中国：医薬品受託包装市場（単位：百万米ドル）、2019年&2024年
図16：中国：医薬品受託包装市場の予測（単位：百万ドル医薬品受託包装市場の予測（単位：百万米ドル、2025年～2033年
図17: インド：医薬品受託包装市場（単位：百万米ドル）、2019年および2024年
図18：インド：医薬品受託包装市場の予測（単位：百万ドル医薬品受託包装市場の予測（単位：百万米ドル、2025年～2033年
図19：その他：医薬品受託包装市場（単位：百万米ドル）、2019年および2024年
図20：その他：医薬品受託包装市場の予測（単位：百万米ドル、2025年〜2033年
図21：世界：医薬品受託包装（低分子）市場：販売額（単位：百万米ドル）、2019年 & 2024年
図22：世界の医薬品受託包装（低分子）市場予測：販売額（単位：百万米ドル）、2025年～2033年
図23: 医薬品受託包装（バイオ医薬品）の世界市場：販売額（単位：百万米ドル）、2019年・2024年
図24：医薬品受託包装（バイオ医薬品）の世界市場予測：販売額（単位：百万米ドル）、2025年～2033年
図25：世界：医薬品受託包装（ワクチン）市場：販売額（単位：百万米ドル）、2019年・2024年
図26：世界：医薬品受託包装（ワクチン）市場予測：販売額（単位：百万米ドル）、2025年～2033年
図27：世界：医薬品包装受託（無菌）市場：販売額（単位：百万米ドル）、2019年・2024年
図28：世界：医薬品包装受託（無菌）市場予測：販売額（単位：百万米ドル）、2025年～2033年
図29：世界：医薬品包装受託（非滅菌）市場：販売額（単位：百万米ドル）、2019年・2024年
図30：世界：医薬品受託包装（非ステライル）市場予測：販売額（単位：百万米ドル）、2025年～2033年
図31：世界：医薬品受託包装（プラスチックボトル）市場：販売額（単位：百万米ドル）、2019年・2024年
図32：世界：医薬品受託包装（プラスチックボトル）市場予測：販売額（単位：百万米ドル）、2025年～2033年
図33：世界：医薬品受託包装（キャップ・クロージャー）市場：販売額（単位：百万米ドル）、2019年・2024年
図34：世界：医薬品受託包装（キャップ・クロージャー）市場予測：販売額（単位：百万米ドル）、2025年～2033年
図35：世界：医薬品受託包装（ブリスターパック）市場：販売額（単位：百万米ドル）、2019年・2024年
図36：世界：医薬品受託包装（ブリスターパック）市場予測：販売額（単位：百万米ドル）、2025年～2033年
図37：世界：医薬品受託包装（プレフィルドシリンジ）市場：販売額（単位：百万米ドル）、2019年・2024年
図38：世界：医薬品受託包装（プレフィルドシリンジ）市場予測：販売額（単位：百万米ドル）、2025年～2033年
図39：世界：医薬品受託包装（非経口バイアル・アンプル）市場：販売額（単位：百万米ドル）、2019年・2024年
図40：世界：医薬品受託包装（非経口バイアル、アンプル）市場予測：販売額（単位：百万米ドル）、2025年～2033年
図41：世界：医薬品受託包装（その他）市場：販売額（単位：百万米ドル）、2019年・2024年
図42：世界：医薬品受託包装（その他）市場予測：販売額（単位：百万米ドル）、2025年～2033年
図43：医薬品受託包装：詳細なプロセスフロー
図44：医薬品受託包装：原料の転換率
図45：医薬品受託包装工場：工場レイアウト案
図 46：医薬品受託包装工場：資本コストの内訳(%)
図 47：医薬品受託包装業界：サプライチェーンの各レベルにおける利益率
図 48：医薬品受託包装工場：製造コストの内訳（単位）
[表一覧］
表1：世界：医薬品受託包装市場：主要産業ハイライト、2024年と2033年
表2：世界：医薬品受託包装市場予測：表2：医薬品受託包装の世界市場予測：産業別内訳（単位：百万米ドル）、2025年〜2033年
表3：医薬品受託包装の世界市場予測：タイプ別構成比（単位：百万米ドル）、2025年〜2033年
表4：医薬品受託包装の世界市場予測：包装別の内訳（単位：百万米ドル）、2025-2033年
表5：医薬品受託包装の世界市場予測：地域別内訳（単位：百万米ドル）、2025-2033年
表6：医薬品受託包装の世界市場：競争構造
表7：医薬品受託包装の世界市場：競争構造主要企業
表8：医薬品受託包装工場：土地と用地開発に関するコスト（単位：米ドル）
表9: 医薬品受託包装工場：土木工事関連コスト（単位：米ドル）
表10: 医薬品受託包装工場: 土木関連費用 (単位:米ドル)医薬品受託包装工場：機械ユニット関連費用（単位：米ドル）
表11: 医薬品受託包装工場：医薬品受託包装工場：原材料所要量（トン/日）と支出（単位：米ドル/トン）
表12: 医薬品受託包装工場：給与・賃金関連費用（単位：米ドル）
表13: 医薬品受託包装工場：その他の設備投資に関する費用（単位：米ドル）
表14：金融機関が提供する資金援助の詳細
表15: 医薬品受託包装工場：資本コスト（単位：米ドル）
表16: 医薬品受託包装工場：技術経済パラメーター
表17: 医薬品受託包装工場：課税と減価償却費（単位：米ドル）
表18: 医薬品受託包装工場：収入予測（単位：米ドル）
表19: 医薬品受託包装工場：支出予測(単位:米ドル)
表20: 医薬品受託包装工場：法人税負担を考慮しないキャッシュフロー分析（単位：米ドル）
表21: 医薬品受託包装工場：所得税負担を考慮したキャッシュフロー分析 (単位:米ドル)
表22: 医薬品受託包装工場：損益勘定（単位：米ドル）
The global pharmaceutical contract packaging market size reached USD 23.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 41.9 Billion by 2033, exhibiting a growth rate (CAGR) of 6.47% during 2025-2033. The increasing outsourcing trends, rising demand for medications and medical devices, stringent regulatory compliance, product diversification and cost-effectiveness, significant technological advancements, and increasing environmental considerations are some of the major factors propelling the market.
Pharmaceutical contract packaging refers to the outsourcing of packaging services by pharmaceutical companies to specialized contract packaging firms. These firms are equipped with the necessary infrastructure and expertise to handle the packaging of pharmaceutical products, including medications, medical devices, and related healthcare items. The process of pharmaceutical contract packaging involves various stages, including design, labeling, and assembly of the final product packaging. The contract packaging companies ensure compliance with regulatory guidelines and industry standards, such as Good Manufacturing Practices (GMP) and Quality Assurance (QA) protocols. By opting for contract packaging services, pharmaceutical companies can benefit from several advantages. It allows them to focus on their core competencies, such as research and development, while entrusting packaging responsibilities to experts. This leads to increased operational efficiency and reduced time-to-market for their products. Additionally, contract packaging firms can offer cost-effective solutions by leveraging economies of scale and optimizing packaging processes.
Pharmaceutical companies are increasingly outsourcing their non-core activities, including packaging, to contract packaging firms. This allows them to focus on core competencies like research and development, while benefiting from the expertise and efficiency of contract packaging specialists. Additionally, the pharmaceutical industry is subject to strict regulations and quality standards imposed by health authorities worldwide. Contract packaging companies are well-versed in these regulations, ensuring that pharmaceutical products are packaged and labeled in compliance with Good Manufacturing Practices (GMP) and other relevant guidelines. Other than this, the pharmaceutical market is continuously expanding with new drug developments, personalized medicines, and innovative medical devices. Contract packaging firms offer customized and flexible solutions to accommodate the diverse packaging requirements of these products. Besides this, contract packaging offers cost advantages to pharmaceutical companies by eliminating the need for heavy investments in packaging infrastructure and equipment. Instead, they can leverage the capabilities of established contract packaging providers, resulting in cost savings. In line with this, the global pharmaceutical industry is witnessing significant growth, especially in emerging markets. As pharmaceutical companies expand their reach to new regions, they seek reliable contract packaging partners to ensure efficient and compliant packaging in diverse markets. Furthermore, contract packaging companies are continually adopting advanced technologies and automation in their processes. These innovations improve packaging efficiency, reduce errors, and enhance overall productivity, making them attractive partners for pharmaceutical firms. Moreover, increasing awareness about sustainability and environmental impact has led to a growing demand for eco-friendly and recyclable packaging solutions. Contract packaging companies are aligning their offerings with these green initiatives to meet market demands.
Pharmaceutical Contract Packaging Market Trends/Drivers:
Increasing Outsourcing Trend
Pharmaceutical companies are increasingly turning to contract packaging firms to handle their packaging needs. This shift is primarily driven by the desire to focus on core competencies, such as drug development and marketing, while entrusting the specialized task of packaging to experienced professionals. By outsourcing packaging, pharmaceutical companies can streamline their operations, reduce operational costs, and improve overall efficiency. Contract packaging firms offer expertise in packaging materials, design, and regulatory compliance, which allows pharmaceutical companies to deliver high-quality products to the market in a timely manner. Additionally, outsourcing provides the flexibility to adapt to fluctuations in product demand, allowing pharmaceutical companies to respond swiftly to changing market dynamics.
Stringent Regulatory Compliance
The pharmaceutical industry is heavily regulated by various health authorities worldwide to ensure patient safety and product efficacy. Compliance with Good Manufacturing Practices (GMP) and other regulatory guidelines is paramount for pharmaceutical companies. Contract packaging firms specialize in adhering to these strict regulations, as they possess in-depth knowledge of the applicable quality standards and industry best practices. Their expertise ensures that pharmaceutical products are accurately labeled, packaged, and traceable throughout the supply chain, reducing the risk of non-compliance and potential legal issues. By partnering with contract packaging providers, pharmaceutical companies can maintain their reputation for producing safe and reliable products, while mitigating the risks associated with regulatory non-compliance.
Rising Demand for Medications and Medical Devices
The global pharmaceutical market is continuously expanding, with increasing demand for medications and medical devices across diverse regions. As pharmaceutical companies seek to penetrate new markets, they encounter unique packaging requirements and regional regulations. Contract packaging firms offer localized expertise and capabilities, enabling pharmaceutical companies to navigate the complexities of different markets seamlessly. These firms can adapt packaging designs, labeling, and language translations to comply with local regulations and cultural preferences. By partnering with contract packaging providers, pharmaceutical companies can efficiently enter new markets, capitalize on growth opportunities, and reach a broader customer base. This market expansion strategy allows pharmaceutical companies to extend their market presence while minimizing logistical challenges and ensuring a consistent and compliant packaging approach.
Pharmaceutical Contract Packaging Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global pharmaceutical contract packaging market report, along with forecasts at the global and regional levels for 2025-2033. Our report has categorized the market based on industry, type and packaging.
Breakup by Industry:
• Small Molecule
• Biopharmaceutical
• Vaccine
The report has provided a detailed breakup and analysis of the market based on the industry. This includes small molecule, biopharmaceutical, and vaccine.
The small molecule pharmaceutical industry encompasses a broad range of traditional drugs that consist of low molecular weight compounds. These drugs are typically synthesized through chemical processes, and they constitute a significant portion of the pharmaceutical market. Small molecule drugs are widely used to treat various medical conditions and diseases, including cardiovascular disorders, infectious diseases, and metabolic disorders. Due to their relatively simple structure, small molecules can be easily mass-produced and formulated into different dosage forms, such as tablets and capsules. They also have a well-established manufacturing and packaging process, making them cost-effective to produce and distribute. The small molecule pharmaceutical industry remains a vital segment of the overall pharmaceutical market and continues to experience steady growth due to the constant demand for therapeutics targeting prevalent medical conditions.
The biopharmaceutical industry focuses on the development and production of pharmaceutical products derived from biological sources, such as living organisms or their components. Biopharmaceuticals include a wide range of products like monoclonal antibodies, vaccines, recombinant proteins, and gene therapies. These products are often more complex in structure and require advanced manufacturing processes, including biotechnology techniques like cell culture and genetic engineering. The biopharmaceutical sector has witnessed significant growth in recent years due to the increasing prevalence of chronic diseases, personalized medicine approaches, and advancements in biotechnology research. Biopharmaceutical products offer targeted and precise treatments, which have revolutionized disease management and patient care. As a result, this industry has become a key driver of innovation and growth within the pharmaceutical market.
The vaccine industry is dedicated to the development, manufacturing, and distribution of vaccines that prevent infectious diseases and protect public health. Vaccines are biological products designed to stimulate an immune response, providing immunity against specific pathogens. They play a crucial role in preventing the spread of communicable diseases and reducing the burden of infectious outbreaks. The vaccine industry has experienced remarkable growth and technological advancements, particularly in response to global health challenges like the COVID-19 pandemic. Vaccine development requires rigorous testing, clinical trials, and adherence to stringent regulatory standards to ensure safety and efficacy. The ongoing research in immunology and molecular biology continues to drive the innovation of novel vaccines to combat emerging diseases and improve public health outcomes globally. As governments and healthcare organizations prioritize vaccination programs, the vaccine industry remains a vital and indispensable component of the pharmaceutical market.
Breakup by Type:
• Sterile
• Non-Sterile
Sterile pharmaceutical contract packaging holds the largest share in the market
A detailed breakup and analysis of the market based on the type has also been provided in the report. This includes sterile and non-sterile. According to the report, sterile packaging accounted for the largest market share.
Sterile products are those that are free from any viable microorganisms, making them suitable for direct administration into the body, such as through injections or infusions. They are essential in various medical settings, including hospitals, clinics, and home healthcare. The sterile products are widely used in treating serious and life-threatening medical conditions that require immediate and precise intervention. These products are crucial in emergency situations and surgical procedures, where contamination can have severe consequences. Additionally, the stringent regulatory requirements surrounding the manufacturing and distribution of sterile products contribute to their significance. Health authorities have strict guidelines to ensure the quality and sterility of these products, making the manufacturing process complex and specialized. Moreover, the growing demand for biopharmaceuticals and injectable drugs has further driven the dominance of the sterile segment. As biologics and personalized medicine gain popularity, the need for sterile packaging and administration becomes more pronounced, propelling the growth of this segment within the pharmaceutical market.
Breakup by Packaging:
• Plastic Bottles
• Caps and Closures
• Blister Packs
• Prefilled Syringes
• Parenteral Vials and Ampoules
• Others
Plastic bottles dominate the market
The report has provided a detailed breakup and analysis of the market based on the packaging. This includes plastic bottles caps and closures, blister packs, prefilled syringes, parenteral vials and ampoules, and others. According to the report, plastic bottles represented the largest segment.
Plastic bottles offer a combination of versatility and cost-effectiveness that makes them widely preferred across various industries, including pharmaceuticals. Their lightweight nature and durability make them easy to handle during manufacturing, transportation, and storage, reducing overall logistics costs. Additionally, plastic bottles provide excellent barrier properties, protecting pharmaceutical products from external contaminants, moisture, and UV light. This safeguard helps maintain product integrity and extends shelf life, ensuring that medications and healthcare products remain effective and safe for consumption. Furthermore, plastic bottles come in a wide range of shapes and sizes, allowing for customization to meet specific packaging requirements. This flexibility makes them suitable for packaging various forms of pharmaceuticals, from liquid syrups and oral medications to solid tablets and capsules. Moreover, the recyclability of plastic bottles aligns with growing environmental concerns, as manufacturers and consumers increasingly prioritize sustainable packaging solutions. As the demand for eco-friendly packaging continues to rise, plastic bottles' recyclability contributes to their continued dominance as the largest segment in the pharmaceutical packaging market.
Breakup by Region:
• United States
• Europe
• China
• India
• Others
The United States exhibits a clear dominance in the market
The report has also provided a comprehensive analysis of all the major regional markets, which include the United States, Europe, China, India, and others. According to the report, the United States was the largest market for pharmaceutical contract packaging.
The U.S. pharmaceutical market is one of the largest and most developed in the world, with a high demand for innovative drugs, medical devices, and healthcare products. The extensive pharmaceutical industry in the U.S. necessitates a robust contract packaging sector to handle the diverse packaging needs of various companies. Additionally, the U.S. pharmaceutical landscape is characterized by a dynamic regulatory environment, with stringent quality and safety standards enforced by agencies such as the Food and Drug Administration (FDA). Contract packaging companies in the U.S. are well-versed in these regulations and adhere to strict compliance protocols, providing assurance to pharmaceutical companies that their products will meet the necessary requirements. Other than this, the U.S. is home to numerous pharmaceutical companies, ranging from multinational corporations to innovative start-ups. Many of these companies prefer to outsource their packaging needs to specialized contract packaging firms to focus on their core competencies and achieve greater operational efficiency. Moreover, the presence of advanced technologies and infrastructure in the U.S. contributes to the country's dominance in the pharmaceutical contract packaging market. These resources enable contract packaging companies to offer a wide array of packaging solutions, including serialization, track-and-trace systems, and customized packaging designs. Furthermore, the U.S. contract packaging industry benefits from a highly skilled and trained workforce with expertise in various aspects of pharmaceutical packaging. This proficiency ensures that contract packaging companies can deliver high-quality and reliable packaging services to their clients.
Competitive Landscape:
Leading contract packaging companies are investing heavily in advanced technologies and automation systems. These investments aim to streamline packaging processes, reduce manual errors, and improve overall operational efficiency. Automation enables faster and more precise packaging, leading to increased production capacities and shorter time-to-market for pharmaceutical products. Additionally, key players in the market are expanding their geographic presence to tap into emerging markets and cater to the growing demand for contract packaging services globally. By establishing facilities in strategic locations, they can provide localized services and offer more cost-effective solutions to pharmaceutical companies seeking to enter new regions. Other than this, environmental sustainability has become a significant concern for consumers and businesses alike. Many key players in the pharmaceutical contract packaging market are incorporating sustainable practices, such as using eco-friendly materials and optimizing packaging designs to reduce waste. These efforts align with the increasing demand for environmentally responsible packaging solutions. Furthermore, to broaden their service offerings and cater to diverse customer needs, key players often engage in collaborations and partnerships. These collaborations may involve joint ventures, technology-sharing agreements, or strategic alliances with pharmaceutical companies and other stakeholders. Such partnerships foster innovation, knowledge exchange, and access to a wider customer base.
The market research report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided.
Key Questions Answered in This Report
1.What was the size of the global pharmaceutical contract packaging market in 2024?
2.What is the expected growth rate of the global pharmaceutical contract packaging market during 2025-2033?
3.What are the key factors driving the global pharmaceutical contract packaging market?
4.What has been the impact of COVID-19 on the pharmaceutical contract packaging market?
5.What is the breakup of the global pharmaceutical contract packaging market based on the type?
6.What is the breakup of the global pharmaceutical contract packaging market based on the packaging?
7.What are the key regions in the global pharmaceutical contract packaging market?
